Hamps Bio Ltd
Fundamental Score
Hamps Bio Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of HAMPS across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (71.99%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Below-Average Return on Equity (4.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.68%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-174.07%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (0.12x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Hamps Bio Ltd
About HAMPS
Business Overview
Hamps Bio Limited provides pharmaceutical, freeze dried, and frozen products in India and internationally. The company offers nutrition supplement, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ready to eat food, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. The company sells its products under the HAMPS and FzyEzy brands through distribution network and e-commerce platform. Hamps Bio Limited was incorporated in 2007 and is based in Surat, India.
Company Details
Key Leadership
Latest News
HAMPS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Hamps Bio Ltd (HAMPS)?
As of 29 Jan 2026, 10:39 am IST, Hamps Bio Ltd (HAMPS) is currently trading at ₹17.11. The stock has a market capitalization of ₹21.34 (Cr).
Is HAMPS share price Overvalued or Undervalued?
HAMPS is currently trading at a P/E ratio of 0.00x, compared to the industry average of 21.07x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Hamps Bio Ltd share price?
Key factors influencing HAMPS's price include its quarterly earnings growth (Sales Growth: 12.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Hamps Bio Ltd a good stock for long-term investment?
Hamps Bio Ltd shows a 5-year Profit Growth of N/A% and an ROE of 4.94%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.44 before investing.
How does Hamps Bio Ltd compare with its industry peers?
Hamps Bio Ltd competes with major peers in the Other Agricultural Products. Investors should compare HAMPS's P/E of 0.00x and ROE of 4.94% against the industry averages to determine its competitive standing.
What is the P/E ratio of HAMPS and what does it mean?
HAMPS has a P/E ratio of N/Ax compared to the industry average of 21.07x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is HAMPS performing according to Bull Run's analysis?
HAMPS has a Bull Run fundamental score of 16.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does HAMPS belong to?
HAMPS operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Hamps Bio Ltd.
What is Return on Equity (ROE) and why is it important for HAMPS?
HAMPS has an ROE of 4.94%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Hamps Bio Ltd generates profits from shareholders' equity.
How is HAMPS's debt-to-equity ratio and what does it indicate?
HAMPS has a debt-to-equity ratio of 0.44, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is HAMPS's dividend yield and is it a good dividend stock?
HAMPS offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has HAMPS grown over the past 5 years?
HAMPS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in HAMPS and why does it matter?
Promoters hold 71.99% of HAMPS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is HAMPS's market capitalization category?
HAMPS has a market capitalization of ₹21 crores, placing it in the Small-cap category.
How volatile is HAMPS stock?
HAMPS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for HAMPS?
HAMPS has a 52-week high of ₹N/A and low of ₹N/A.
What is HAMPS's operating profit margin trend?
HAMPS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is HAMPS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 12.71% and YoY Profit Growth of -174.07%.
What is the institutional holding pattern in HAMPS?
HAMPS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.